Dr Reddy's shares up on Hepatitis C drug launch plan
Shares of Dr Reddy's Laboratories on Tuesday settled with gains of nearly 2 percent after the firm said it is planning to launch Hepatitis C drug in the country, following which its market capitalisation rose Rs 1,000 crore.
Mar 24, 2015, 19:08 PM IST